Stephanie Saw

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Stephanie Saw
Apr 9, 2025, 14:42 | Blog
Stephanie Saw: Distant Cousins From the Same Family—Understanding Uncommon EGFR Mutations
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, shared a paper she and…
Mar 27, 2025, 13:04 | Blog
Crispin Hiley: Stephanie Saw on Post-Osimertinib Decision Making in EGFR+ NSCLC
Crispin Hiley, UK Clinical Director for Lung Cancer at GenesisCare, shared a post on X:…
Feb 22, 2025, 14:43 | Blog
Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Feb 18, 2025, 18:35 | Science
Giannis Mountzios: Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Feb 18, 2025, 10:44 | Science
Stephanie Saw: Our review paper on ADCs in NSCLC with AGA is out
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, reshared a post by Giannis…
Jan 13, 2025, 20:21 | Insight
Navneet Singh: Expert consensus statement on the peri-operative management of NSCLC
Navneet Singh, Thoracic Medical Oncologist at the Postgraduate Institute of Medical Education and Research, shared…
Jan 9, 2025, 11:42 | Insight
Hidehito Horinouchi: ATORG expert consensus statement on the peri-operative management of NSCLC
A recent paper by Stephanie Saw, Medical Oncologist at National Cancer Centre Singapore, was mentioned…
Dec 25, 2024, 15:09 | Blog
Stephanie Saw: First line and post-progression treatment options for advanced EGFR-mutated NSCLC
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, shared a post on X:…
Dec 9, 2024, 20:11 | Insight
Sanjay Popat: Stephanie Saw discusses Asian subset data from osimertinib
Sanjay Popat, Thoracic Oncologist at The Royal Marsden NHS Foundation Trust, shared on X: “Stephanie…
Jun 21, 2024, 09:39 | Insight
Stephanie Saw: Real-world evidence of adding pemetrexed-platinum chemotherapy upon osimertinib progression
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, shared on X/Twitter: "Just out in…
Apr 5, 2024, 08:01 | Blog
Jordi Remon: In this ASCO Educational Book we summarize EGFR mutated lung cancer
Jordi Remon, Coordinator of the Cancer Medicine Department at CIOCC Barcelona – HM Nou Delfos,…
All: 11 Posts: 1 - 100
Special Coverage